Blar i Institutt for klinisk og molekylær medisin på forfatter "Dahl, Alv A"
-
Mortality and Second Cancer Incidence after Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
Fosså, Sophie Dorothea; Dahl, Alv A; Thorsen, Lene; Hellesnes, Ragnhild; Kiserud, Cecilie E.; Tandstad, Torgrim; Brydøy, Marianne; Haugnes, Hege Sagstuen; Myklebust, Tor Åge (Peer reviewed; Journal article, 2022)PURPOSE To evaluate whether selected modifiable patient-reported adverse health outcomes (AHOs) in testicular cancer survivors (TCSs) represent prognostic factors of overall mortality, cancer mortality, and first-time ... -
Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation
Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald; Seland, Mette; Wilsgaard, Tom; Smeland, Knut Bjøro; Kiserud, Cecilie E. (Journal article; Peer reviewed, 2019)Reduced sexual function may have negative implications on health related quality of life among lymphoma survivors. A national cross-sectional study among long-term lymphoma survivors after high-dose therapy with autologous ... -
Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma
Simensen, Victoria C.; Smeland, Knut Bjøro; Kiserud, Cecilie E.; Dahl, Alv A; Bersvendsen, Hanne Skjerven; Fluge, Øystein; Fagerli, Unn-Merete; Fosså, Alexander (Journal article; Peer reviewed, 2019)Purpose: Lymphoma survivors after high dose therapy with autologous stem cell therapy (HD-ASCT) are at high risk for late adverse effects (AEs). Information patients receive and collect throughout their cancer trajectory ...